Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06892951Phase 1/2Recruiting
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia
Pneumocystis InfectionsPneumocystis Jirovecii InfectionPneumocystis Pneumonia
StudydirectorStart date: 2025-12-02

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University Hospital of TOURS

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Adrien LEMAIGNEN, Dr

University Hospital of TOURS

Moderately Similar
1 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumocystis jirovecii InfectionPneumonia, Pneumocystis

Worked with same sponsors:

AerogenAmiens University Hospital+26 more
Collaborated on 1 trial
Similarity Score34%

Stephan EHRMANN, Prof

University Hospital of TOURS

Moderately Similar
1 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumocystis jirovecii InfectionPneumonia, Pneumocystis

Worked with same sponsors:

AerogenAmiens University Hospital+26 more
Collaborated on 1 trial
Similarity Score34%

Matthew P Cheng, MD FRCPC

McGill University Health Centre/Research Institute of the McGill University Health Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Pneumocystis jirovecii InfectionPneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score30%

Emily G McDonald, MD MSc

Research Institute of the McGill University Health Centre

Moderately Similar
4 trials

Shared therapeutic areas:

Pneumocystis jirovecii InfectionPneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score30%

Todd C Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Moderately Similar
2 trials

Shared therapeutic areas:

Pneumocystis jirovecii InfectionPneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score30%

Emily G McDonald, MD MSc

McGill University Health Centre/Research Institute of the McGill University Health Centre

Moderately Similar
3 trials

Shared therapeutic areas:

Pneumocystis jirovecii InfectionPneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score30%

Joseph A Kovacs, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
4 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score20%

Robert Murphy

Related
1 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis
Similarity Score10%

Todd C. Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Related
2 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis
Similarity Score10%

Walter T Hughes

Related
1 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06892951Phase 1/2StudyDirector

CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia

Pneumocystis InfectionsPneumocystis Jirovecii InfectionPneumocystis Pneumonia
Recruiting

All 1 trials loaded